Eli Lilly and Company's Fiscal Year is From January To December - All Figures are in Percent.
The item "Pretax-Margin" stands at 37.87 percent as of 09/30/2025, the highest value at least since 06/30/2022, the period currently displayed.
As of the end of Eli Lilly and Company's third quarter, the item "Pretax Margin" stands at 37.87 Percent. This represents an increase of 6.22 percentage points compared to it's value at the end of it's second quarter .
Regarding the One-Year-Change of the series, the current value constitutes an increase of 13.03 percentage points compared to the value the year prior.
The 1 year change in percentage points is 13.03.
The 3 year change in percentage points is 15.47.
| Logo | Name | Market Cap (USD) |
|---|---|---|
![]() | Johnson & Johnson - Pretax Margin | 486,508,953,600.00 |
![]() | AbbVie Inc - Pretax Margin | 399,570,305,024.00 |
![]() | Roche Holding AG - Pretax Margin | 317,433,206,677.55 |
![]() | AstraZeneca PLC - Pretax Margin | 280,205,508,085.11 |
![]() | Novartis AG - Pretax Margin | 255,096,620,580.91 |